Acquiring Actigenics, Cepheid Adds microRNA to Molecular Dx Business; Eyes Companion Dx Role

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

Acquiring Actigenics, Cepheid Adds microRNA to Molecular Dx Business; Eyes Companion Dx Role
By Doug Macron
August 17, 2006
RNAi News
Though Cepheid considers miRNAs to be ?very early-stage markers,? the company was willing to take a chance on Actigenics and an unproven technology.
Paid subscription is required to view article.